Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial
Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial. // Phytomedicine. – URL: https://www.sciencedirect.com/science/article/pii/S0944711326010998?dgcid=rss_sd_all
Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial. Phytomedicine. https://www.sciencedirect.com/science/article/pii/S0944711326010998?dgcid=rss_sd_all
“Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial.” Phytomedicine.
@article{article117542,
title = {Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial},
journal = {Phytomedicine},
url = {https://www.sciencedirect.com/science/article/pii/S0944711326010998?dgcid=rss_sd_all}
}